678 related articles for article (PubMed ID: 25910483)
21. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
[TBL] [Abstract][Full Text] [Related]
22. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
Xue F; He X
Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
25. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
28. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
[TBL] [Abstract][Full Text] [Related]
29. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus and nasopharyngeal carcinoma.
Young LS; Dawson CW
Chin J Cancer; 2014 Dec; 33(12):581-90. PubMed ID: 25418193
[TBL] [Abstract][Full Text] [Related]
32. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
33. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
[TBL] [Abstract][Full Text] [Related]
34. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
Mizokami H; Okabe A; Choudhary R; Mima M; Saeda K; Fukuyo M; Rahmutulla B; Seki M; Goh BC; Kondo S; Dochi H; Moriyama-Kita M; Misawa K; Hanazawa T; Tan P; Yoshizaki T; Fullwood MJ; Kaneda A
EBioMedicine; 2024 Apr; 102():105057. PubMed ID: 38490101
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Tsao SW; Wong HL; Hui JW; To KF; Hayward DS; Chui YL; Lau YL; Takada K; Huang DP
Neoplasia; 2006 Mar; 8(3):173-80. PubMed ID: 16611410
[TBL] [Abstract][Full Text] [Related]
36. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
38. The biology of EBV infection in human epithelial cells.
Tsao SW; Tsang CM; Pang PS; Zhang G; Chen H; Lo KW
Semin Cancer Biol; 2012 Apr; 22(2):137-43. PubMed ID: 22497025
[TBL] [Abstract][Full Text] [Related]
39. Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana.
Ayee R; Ofori MEO; Tagoe EA; Languon S; Searyoh K; Armooh L; Bilson-Amoah E; Baidoo K; Kitcher E; Wright E; Quaye O
Viruses; 2020 Jul; 12(7):. PubMed ID: 32708700
[TBL] [Abstract][Full Text] [Related]
40. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]